Home / MissionIR Articles / CytoSorbents Corp. (CTSO) Starts Presentation at 2nd Annual Marcum MicroCap Conference

CytoSorbents Corp. (CTSO) Starts Presentation at 2nd Annual Marcum MicroCap Conference

CytoSorbents is a critical care-focused therapeutic device company using blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses. CTSO’s purification technology removes toxic substances from blood and other bodily fluids. The company’s flagship product, CytoSorb®, is approved in the European Union as a safe and effective means to reduce the “cytokine storm” that could otherwise cause massive inflammation, organ failure and death. For more information visit the company’s Web site at www.cytosorbents.com

Let us hear your thoughts below: